Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07153627

Rectal Ozone as Neuroprotector Post CNS Insult in Children

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
1 Month – 18 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the efficacy of rectal ozone therapy as a neuroprotective modality in Pediatric acquired brain injury.

Detailed description

Acquired brain injury (ABI) from primary neurologic diagnoses accounts for 20% of all pediatric critical care admissions and more than 60,000 hospital admissions annually. Ozone (O3) gas was discovered in the 1840s, and soon after that, the scientific community began to expand past the notion that it was just another gas of the Earth's atmosphere.

Conditions

Interventions

TypeNameDescription
OTHERRectal ozone sessionsPatients will receive 40 Rectal ozone sessions or until improvement (maximum 80 sessions), in addition to their conventional rehabilitation program.
OTHERConventional rehabilitation programPatients will receive their conventional rehabilitation program only (physiotherapy sessions three times per week for the treatment period (six months).

Timeline

Start date
2025-05-01
Primary completion
2025-10-01
Completion
2025-10-01
First posted
2025-09-04
Last updated
2025-09-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07153627. Inclusion in this directory is not an endorsement.